Analysis of differential proteomes in pathogenic and non-pathogenic Leptospira: Potential pathogenic and virulence factors

Proteomics

Volumn 9, Issue 13, 2009, Pages 3522-3534

  Thongboonkerd, Visith ^a   Chiangjong, Wararat ^a   Saetun, Putita ^a   Sinchaikul, Supachok ^b   Chen, Shui Tein ^b,c   Kositanont, Uraiwan ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

^b INSTITUTE OF BIOLOGICAL CHEMISTRY   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

Leptospirosis; Pathogenic factors; Spirochete; Virulence factors

Indexed keywords

BACTERIAL PROTEIN; PROTEOME; VIRULENCE FACTOR;

ARTICLE; BACTERIAL VIRULENCE; CONTROLLED STUDY; DISEASE SEVERITY; LEPTOSPIRA; LEPTOSPIRA BIFLEXA; LEPTOSPIRA INTERROGANS; LEPTOSPIROSIS; MASS SPECTROMETRY; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEOMICS; QUANTITATIVE ANALYSIS; WESTERN BLOTTING;

BACTERIAL PROTEINS; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; LEPTOSPIRA; MASS SPECTROMETRY; PROTEOME; PROTEOMICS; VIRULENCE FACTORS;

BACTERIA (MICROORGANISMS); LEPTOSPIRA; LEPTOSPIRA BIFLEXA; LEPTOSPIRA INTERROGANS; SPIROCHAETALES;

EID: 67651238379     PISSN: 16159853     EISSN: 16159861     Source Type: Journal    
DOI: 10.1002/pmic.200700855     Document Type: Article

References (25)

1. Bharti, A. R., Nally, J. E., Ricaldi, J. N., Matthias, M. A. et al., Leptospirosis: a zoonotic disease of global importance. Lancet Infect. Dis. 2003, 3, 757-771.
2. Levett, P. N., Leptospirosis. Clin. Microbiol. Rev. 2001, 14, 296-326.
3. Terpstra, W. J., Typing leptospira from the perspective of a reference laboratory. Acta Leiden 1992, 60, 79-87.
4. Sitprija, V., Renal dysfunction in leptospirosis: a view from the tropics. Nat. Clin. Pract. Nephrol. 2006, 2, 658-659.
5. Palaniappan, R. U., Ramanujam, S., Chang, Y. F., Leptospirosis: pathogenesis, immunity, and diagnosis. Curr. Opin. Infect. Dis. 2007, 20, 284-292.
6. Ren, S. X., Fu, G., Jiang, X. G., Zeng, R. et al., Unique physiological and pathogenic features of Leptospira interrogans revealed by whole-genome sequencing. Nature 2003, 422, 888-893.
7. Nascimento, A. L., Verjovski-Almeida, S., Van Sluys, M. A., Monteiro-Vitorello, C. B. et al., Genome features of Leptospira interrogans serovar Copenhageni. Braz. J. Med. Biol. Res. 2004, 37, 459-477.
8. Bulach, D. M., Zuerner, R. L., Wilson, P., Seemann, T. et al., Genome reduction in Leptospira borgpetersenii reflects limited transmission potential. Proc. Natl. Acad. Sci. USA 2006, 103, 14560-14565.
9. Guerreiro, H., Croda, J., Flannery, B., Mazel, M. et al., Leptospiral proteins recognized during the humoral immune response to leptospirosis in humans. Infect. Immun. 2001, 69, 4958-4968.
10. Cullen, P. A., Cordwell, S. J., Bulach, D. M., Haake, D. A. et al., Global analysis of outer membrane proteins from Leptospira interrogans serovar Lai. Infect. Immun. 2002, 70, 2311-2318.
11. Nally, J. E., Whitelegge, J. P., Aguilera, R., Pereira, M. M. et al., Purification and proteomic analysis of outer membrane vesicles from a clinical isolate of Leptospira interrogans serovar Copenhageni. Proteomics 2005, 5, 144-152.
12. Nally, J. E., Whitelegge, J. P., Bassilian, S., Blanco, D. R. et al., Characterization of the outer membrane proteome of Leptospira interrogans expressed during acute lethal infection. Infect. Immun. 2007, 75, 766-773.
13. Kositanont, U., Saetun, P., Krittanai, C., Doungchawee, G. et al., Application of immunoproteomics to leptospirosis: towards clinical diagnostics and vaccine discovery. Proteomics Clin. Appl. 2007, 1, 400-409.
14. Viriyakosol, S., Matthias, M. A., Swancutt, M. A., Kirkland, T. N. et al., Toll-like receptor 4 protects against lethal Leptospira interrogans serovar icterohaemorrhagiae infection and contributes to in vivo control of leptospiral burden. Infect. Immun. 2006, 74, 887-895.
15. Merien, F., Truccolo, J., Baranton, G., Perolat, P., Identification of a 36-kDa fibronectin-binding protein expressed by a virulent variant of Leptospira interrogans serovar icterohaemorrhagiae. FEMS Microbiol. Lett. 2000, 185, 17-22.
16. Ganoza, C. A., Matthias, M. A., Collins-Richards, D., Brouwer, K. C. et al., Determining risk for severe leptospirosis by molecular analysis of environmental surface waters for pathogenic Leptospira. PLoS Med. 2006, 3, e308.
17. Klein, E., Klein, J. B., Thongboonkerd, V., Two-dimensional gel electrophoresis: a fundamental tool for expression proteomics studies. Contrib. Nephrol. 2004, 141, 25-39.
18. Picardeau, M., Brenot, A., Saint, G. I., First evidence for gene replacement in Leptospira spp. Inactivation of L. biflexa flaB results in non-motile mutants deficient in endoflagella. Mol. Microbiol. 2001, 40, 189-199.
19. McBride, A. J., Athanazio, D. A., Reis, M. G., Ko, A. I., Leptospirosis. Curr. Opin. Infect. Dis. 2005, 18, 376-386.
20. Yuri, K., Takamoto, Y., Okada, M., Hiramune, T. et al., Chemotaxis of leptospires to hemoglobin in relation to virulence. Infect. Immun. 1993, 61, 2270-2272.
21. Haake, D. A., Chao, G., Zuerner, R. L., Barnett, J. K. et al., The leptospiral major outer membrane protein LipL32 is a lipoprotein expressed during mammalian infection. Infect. Immun. 2000, 68, 2276-2285.
22. Szeredi, L., Haake, D. A., Immunohistochemical identification and pathologic findings in natural cases of equine abortion caused by leptospiral infection. Vet. Pathol. 2006, 43, 755-761.
23. Hauk, P., Negrotto, S., Romero, E. C., Vasconcellos, S. A. et al., Expression and characterization of HlyX hemolysin from Leptospira interrogans serovar Copenhageni: potentiation of hemolytic activity by LipL32. Biochem. Biophys. Res. Commun. 2005, 333, 1341-1347.
24. Radford, S. E., GroEL: more than just a folding cage. Cell 2006, 125, 831-833.
25. Ellis, R. J., Chaperomics: in vivo GroEL function defined. Curr. Biol. 2005, 15, R661-R663.